Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Michael Millward, Paul Mainwaring, Alain Mita, Kristine Federico, G. K. Lloyd, Natasha Reddinger, Steffan Nawrocki, Monica Mita, Matthew A. Spear

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences